Looks like Sorrento up big time on FDA clearance to start antibody trial. It sure would be be nice to see some kind of positive news about the Generex peptide testing. 22 days now since the last CC...apart from S-1's, we've only seen a PR about the NGIO CC being cancelled. Investors need reassurance that everything is moving in the right direction. Even more so now with the pps in the .20's.